Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia

• Status: Not yet recruiting
• Trial end date: 2024-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to compare ideal body weight- and total body weight-based dosage for remimazolam sedation of obese patients undergoing knee or hip arthroplasty under spinal anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Seoul National University Hospital

Criteria

Inclusion Criteria:

• Patients scheduled for elective knee or hip arthroplasty under spinal anesthesia

• BMI>25

• American Society of Anesthesiologists (ASA) classification I, II, III

Exclusion Criteria:

• Patient refusal

• Contraindication for spinal anesthesia

• Contraindication for remimazolam infusion

• History of hypersensitivity to remimazolam

• History of chronic use of benzodiazepine or opioid

• Baseline MOAA/S score of 4 or lower

• Pregnancy